
Clinical Neuroendocrinology
- 1st Edition, Volume 124 - August 28, 2014
- Imprint: Elsevier
- Editors: Eric Fliers, Marta Korbonits, J.A. Romijn
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 4 - 5 9 6 0 2 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 4 - 6 2 6 1 2 - 7
Clinical Neuroendocrinology, a volume in the Handbook of Clinical Neurology Series gives an overview of the current knowledge in the field of clinical neuroendocrin… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quote- All contributors are recognized experts in the different fields of clinical neuroendocrinology
- The book provides expanded coverage on hypothalamic mechanisms in human pathophysiology
- The book includes current perspectives, diagnosis and treatment of pituitary diseases
Researchers, clinicians and advanced students in the fields of neuroendocrinology, neurology and clinical neuroscience
- Handbook of Clinical Neurology 3rd Series
- Foreword
- Preface
- Section 1: Clinical aspects of hypothalamic function
- Development
- Chapter 1: Genetic aspects of hypothalamic and pituitary gland development
- Abstract
- Introduction
- Development of the hypothalamo-pituitary axis
- Congenital hypopituitarism and associated defects
- Overlap between congenital hypopituitarism and midline defects with kallmann syndrome
- Conclusion and future directions
- Chapter 2: Neuroendocrinology of pregnancy and parturition
- Abstract
- Introduction
- The hypothalamus–pituitary–target gland axes during pregnancy
- The placenta: a neuroendocrine organ
- Stress-related hormones: implications in physiologic pregnancy and parturition and in obstetric complications
- Conclusions
- Chapter 1: Genetic aspects of hypothalamic and pituitary gland development
- Vasopressin, oxytocin, corticotropin-releasing hormone
- Chapter 3: Disorders of water metabolism: diabetes insipidus and the syndrome of inappropriate antidiuretic hormone secretion
- Abstract
- Water metabolism
- Sodium metabolism
- Hypo-osmolality
- Hyperosmolality
- Chapter 4: The role of oxytocin and vasopressin in emotional and social behaviors
- Abstract
- Introduction
- Nonclinical populations
- Clinical populations
- Future directions
- Chapter 5: Corticotropin-releasing hormone and the hypothalamic–pituitary–adrenal axis in psychiatric disease
- Abstract
- Introduction
- Corticotropin-releasing hormone and basal hypothalamic–pituitary–adrenal axis activity
- Hypothalamic–pituitary–adrenal axis functioning in major depression
- Hypothalamic–pituitary–adrenal axis functioning in bipolar disorder
- Hypothalamic–pituitary–adrenal axis functioning in schizophrenia
- Hypothalamic–pituitary–adrenal axis functioning in anxiety disorders
- Conclusion
- Acknowledgments
- Chapter 3: Disorders of water metabolism: diabetes insipidus and the syndrome of inappropriate antidiuretic hormone secretion
- Metabolism
- Chapter 6: Genetic aspects of human obesity
- Abstract
- Introduction
- Human monogenic obesity
- Human pleiotropic and “syndromic” obesity
- New technologies to identify genetic components of obesity
- Conclusions
- Chapter 7: Sleep characteristics and insulin sensitivity in humans
- Abstract
- Introduction
- Sleep physiology and glucose homeostasis
- Sleep deprivation and insulin resistance
- Sleep disorders and insulin resistance
- Diabetes mellitus, metabolic dysregulation, and sleep disorders
- Potential mechanisms linking impaired sleep and insulin resistance
- Future research suggestions
- Chapter 8: Hypothalamic–pituitary hormones during critical illness: a dynamic neuroendocrine response
- Abstract
- Introduction
- The thyroid axis
- The somatotropic axis
- The gonadal axis
- The lactotropic axis
- The adrenal axis
- Conclusions
- Chapter 9: Central regulation of the hypothalamo–pituitary–thyroid (HPT) axis: focus on clinical aspects
- Abstract
- Introduction and outline
- Hypothalamus and pituitary
- Central hypothyroidism
- Central hyperthyroidism
- Conclusion
- Chapter 6: Genetic aspects of human obesity
- Development
- Section 2: Disorders of the pituitary gland
- Diagnostic approach
- Chapter 10: Evaluation of pituitary function
- Abstract
- Introduction
- Reasons for undertaking pituitary investigations
- Approach to the patient in pituitary clinic
- Principles of pituitary assessment
- Basal pituitary blood tests
- Evaluation of the pituitary–adrenal axis
- Evaluation of the pituitary–thyroid axis
- Evaluation of the pituitary–gonadal axis
- Prolactin
- Growth hormone deficiency in adults
- Antidiuretic hormone deficiency: diabetes insipidus
- Conclusion
- Chapter 11: Imaging of pituitary pathology
- Abstract
- Introduction
- Magnetic resonance imaging
- Imaging of pituitary adenomas
- Differential diagnosis
- Computed tomography
- Spect/Pet
- Summary
- Chapter 10: Evaluation of pituitary function
- Pituitary pathologies
- Chapter 12: Nonfunctioning pituitary tumors
- Abstract
- Introduction
- The asymptomatic, incidental, clinically nonfunctioning adenoma (pituitary incidentaloma)
- Symptomatic clinically nonfunctioning adenomas
- Chapter 13: Hyperprolactinemia and prolactinoma
- Abstract
- Introduction
- Causes of hyperprolactinemia
- Clinical features of hyperprolactinemia
- Laboratory assessment of hyperprolactinemia
- Radiologic diagnosis of prolactinomas
- Prevalence rates of prolactinomas
- Treatment of hyperprolactinemia and prolactinoma
- Adverse effects of dopamine agonists
- Withdrawal of dopamine agonist treatment
- Conclusion
- Chapter 14: Acromegaly
- Abstract
- Introduction
- Epidemiology
- Pathophysiology
- Signs and symptoms
- Diagnosis of acromegaly
- Tumoral and functional pituitary assessment
- Prognosis and outcome
- Management and treatment
- Conclusion
- Chapter 15: Cushing's disease
- Abstract
- Introduction
- Clinical features and diagnosis
- Management
- Conclusion
- Notes added in proof
- Chapter 16: Craniopharyngioma
- Abstract
- Introduction
- Epidemiology and pathology
- Clinical manifestations at the time of diagnosis
- Imaging studies
- Treatment strategies
- Sequelae
- Adult-onset craniopharyngioma
- Questions and treatment perspectives
- Conclusions
- Note
- Acknowledgments
- Chapter 17: Rathke's cleft cyst
- Abstract
- Introduction
- Epidemiology
- Pathology
- Pathogenesis
- Presenting manifestations
- Location and imaging features
- Natural history
- Treatment
- Recurrence
- Acknowledgments
- Chapter 18: Alternative causes of hypopituitarism: traumatic brain injury, cranial irradiation, and infections
- Abstract
- Introduction
- Traumatic brain injury
- Cranial irradiation
- Infections in the hypothalamic–pituitary region
- Parasites in the pituitary: toxoplasma gondii
- Summary
- Acknowledgment
- Chapter 12: Nonfunctioning pituitary tumors
- Therapeutic approach to pituitary tumors
- Chapter 19: Surgical approach to pituitary tumors
- Abstract
- Introduction
- Historical background
- Surgery
- Transsphenoidal approaches
- Transcranial approaches
- Complications
- Final remarks
- Chapter 20: Medical approach to pituitary tumors
- Abstract
- Introduction
- Nonfunctional adenoma
- Prolactinoma
- Acromegaly
- Cushing's disease
- Thyrotropin-secrecting adenoma
- Chapter 21: Radiation therapy in the management of pituitary adenomas
- Abstract
- Introduction
- Background on fractionated radiation therapy and single-fraction radiosurgery
- Clinical outcomes of radiation therapy in pituitary adenomas
- Sequelae after radiation therapy
- Conclusion
- Chapter 19: Surgical approach to pituitary tumors
- Diagnostic approach
- Section 3: Controversial issues and hot topics
- Chapter 22: Nelson syndrome: definition and management
- Abstract
- Introduction
- Effective diagnosis of Nelson syndrome
- Predictive factors for the onset and progression of Nelson syndrome
- Pathophysiology of Nelson syndrome
- Pathologic features of corticotropinomas in Nelson syndrome
- Effective management of Nelson syndrome
- Conclusions
- Acknowledgments
- Chapter 23: Familial pituitary tumors
- Abstract
- Introduction
- Pituitary tumorigenesis
- Pituitary adenomas of genetic origin
- Multiple endocrine neoplasia type 1 (MEN1) OMIM #131100
- Familial isolated pituitary adenoma (FIPA): Related omim entries: Pituitary adenoma, growth hormone-secreting #102200 and AIP*605555
- Carney complex syndrome (CNC): Related omim entries: CNC1 #160980, PRKAR1A *188830
- McCune–Albright Syndrome: OMIM 174800
- Conclusion
- Abbreviations
- Chapter 24: Long-term effects of treatment of pituitary adenomas
- Abstract
- Treatment of pituitary adenomas: The historical perspective
- Mortality
- Hypopituitarism and mortality
- Cardiovascular morbidity and pituitary disease
- Failure to mimic physiologic hormone secretion with substitution
- Hypothalamic dysfunction
- Quality of life
- Cognitive function and psychopathology
- Acromegalic arthropathy as a model for disease-specific persistent morbidity
- Implications for treatment and follow-up
- Chapter 25: Neuroendocrine mechanisms in athletes
- Abstract
- Introduction
- Neuroendocrine alterations in athletes
- Impact on bone metabolism of athletic activity and associated neuroendocrine changes
- Impact on neurocognitive function
- Impact on fertility
- Conclusion
- Acknowledgments
- Chapter 26: Uncertainties in endocrine substitution therapy for central hypocortisolism
- Abstract
- Introduction
- Clinical assessment for hypocortisolism
- Dynamic tests of hypocortisolism
- Standard treatments for hypocortisolism
- Conclusions
- Chapter 27: Uncertainties in endocrine substitution therapy for central endocrine insufficiencies: hypothyroidism
- Abstract
- Introduction
- Facts and uncertainties in central hypothyroidism diagnosis
- Facts and uncertainties in central hypothyroidism replacement therapy
- Novel perspectives for therapy of central hypothyroidism
- Chapter 28: Uncertainties in endocrine substitution therapy for central endocrine insufficiencies: growth hormone deficiency
- Abstract
- Introduction
- Patients with isolated growth hormone deficiency (e.g., caused by treatment with prophylactic cranial radiotherapy for lymphoblastic leukemia in childhood)
- Patients with growth hormone deficiency and multiple hormone deficiencies caused by nonsecreting pituitary macroadenomas treated by surgery
- Patients with growth hormone deficiency and multiple hormone deficiencies and with hypothalamic involvement caused by a craniopharyngioma
- General uncertainties of growth hormone therapy
- Conclusion
- Chapter 29: Autoimmune hypophysitis: new developments
- Abstract
- Introduction
- Pituitary autoantibodies
- IGG4-Related hypophysitis
- ANTI-PIT-1 Antibody syndrome
- Autoimmunity and metabolic disease
- Conclusion
- Abbreviations
- Chapter 22: Nelson syndrome: definition and management
- Index
- Edition: 1
- Volume: 124
- Published: August 28, 2014
- No. of pages (Hardback): 456
- No. of pages (eBook): 456
- Imprint: Elsevier
- Language: English
- Hardback ISBN: 9780444596024
- eBook ISBN: 9780444626127
EF
Eric Fliers
MK
Marta Korbonits
She has published over 160 papers, numerous book chapters, and edited two books in the field of Endocrinology and has been an invited speaker on medical conferences all over the world. She serves on the editorial board of several prestigious endocrine journals and serves as referee for numerous high-impact journals and grant-giving bodies. She was heading the Program Organizing Committee of the Society for Endocrinology for three years, served on the Executive Committee of the Pituitary Society and ENEA and currently the European Society of Clinical Investigation and is an elected member of the Association of Physicians of Great Britain and Ireland. She has received numerous awards including the Nicholas Zervas Lectureship at Massachusetts General Hospital, Harvard Medical School and the prestigious Society for Endocrinology Medal.
She shares her time between clinical patient care, clinical research and laboratory based research as well as teaching at undergraduate and postgraduate level.
JR